Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report

Kirby Taylor, Layla Ghergherehchi, Prethy Rao, C. Armitage Harper, Emmanuel Chang

Research output: Contribution to journalArticlepeer-review

Abstract

We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.

Original languageEnglish (US)
Pages (from-to)180-184
Number of pages5
JournalJournal of AAPOS
Volume25
Issue number3
DOIs
StatePublished - Jun 2021
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report'. Together they form a unique fingerprint.

Cite this